The $46m JGC Mirai Innovation Fund will invest in startups working on net-zero emission, green infrastructure, lifestyle and industry 4.0 technologies globally.

Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.

Novo Seeds co-led a $61.7m round for the oncology therapy developer with Ysios Capital, following a Novo Nordisk Foundation grant.

CAS Investment Management has returned for a $34m series A-plus round that was led by CDH Wealth Management.

Amadeus V Technology Fund has closed with $153m in funding, having already backed multiple spinouts.

Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.

The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.

Rakuten took part in a $37m round for virtual kitchen operator Taster while Nano Dimension is buying M12-backed 3D microprinter developer NanoFabrica for up to $54.9m.

Intel, Optum, Relyens and Rezayat Group all invested in the surgery software provider, which is also backed by Mitsubishi, Barco Healthcare, Norgine and Takeda.

Funding from the Anthem-backed series E round will support the commercialisation of Sera's biomarker tests, which predict the chances of preterm births.